nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—OPRM1—nicotine dependence	0.496	0.646	CbGaD
Pimozide—DRD2—nicotine dependence	0.272	0.354	CbGaD
Pimozide—Abnormal behaviour—Varenicline—nicotine dependence	0.00639	0.0752	CcSEcCtD
Pimozide—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00459	0.054	CcSEcCtD
Pimozide—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00363	0.0427	CcSEcCtD
Pimozide—Menstrual disorder—Varenicline—nicotine dependence	0.00349	0.0411	CcSEcCtD
Pimozide—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00316	0.0372	CcSEcCtD
Pimozide—Endocrine disorder—Varenicline—nicotine dependence	0.00287	0.0338	CcSEcCtD
Pimozide—Nocturia—Varenicline—nicotine dependence	0.00257	0.0302	CcSEcCtD
Pimozide—Abnormal dreams—Varenicline—nicotine dependence	0.00235	0.0277	CcSEcCtD
Pimozide—Eructation—Varenicline—nicotine dependence	0.00234	0.0275	CcSEcCtD
Pimozide—Salivary hypersecretion—Varenicline—nicotine dependence	0.00231	0.0272	CcSEcCtD
Pimozide—Increased appetite—Varenicline—nicotine dependence	0.00184	0.0216	CcSEcCtD
Pimozide—Visual disturbance—Varenicline—nicotine dependence	0.00182	0.0214	CcSEcCtD
Pimozide—Droperidol—DRD2—nicotine dependence	0.00176	0.379	CrCbGaD
Pimozide—Urinary retention—Varenicline—nicotine dependence	0.00164	0.0193	CcSEcCtD
Pimozide—Breast disorder—Varenicline—nicotine dependence	0.00156	0.0184	CcSEcCtD
Pimozide—Cramp muscle—Varenicline—nicotine dependence	0.00156	0.0183	CcSEcCtD
Pimozide—Dysphagia—Varenicline—nicotine dependence	0.00149	0.0176	CcSEcCtD
Pimozide—Abdominal discomfort—Varenicline—nicotine dependence	0.00143	0.0168	CcSEcCtD
Pimozide—Pollakiuria—Varenicline—nicotine dependence	0.00138	0.0162	CcSEcCtD
Pimozide—Erectile dysfunction—Varenicline—nicotine dependence	0.00138	0.0162	CcSEcCtD
Pimozide—Weight increased—Varenicline—nicotine dependence	0.00136	0.016	CcSEcCtD
Pimozide—Depression—Varenicline—nicotine dependence	0.00133	0.0156	CcSEcCtD
Pimozide—CACNA1G—brain—nicotine dependence	0.0013	0.0629	CbGeAlD
Pimozide—Connective tissue disorder—Varenicline—nicotine dependence	0.00117	0.0138	CcSEcCtD
Pimozide—Visual impairment—Varenicline—nicotine dependence	0.00115	0.0136	CcSEcCtD
Pimozide—Sertindole—DRD2—nicotine dependence	0.00113	0.244	CrCbGaD
Pimozide—Eye disorder—Varenicline—nicotine dependence	0.00112	0.0131	CcSEcCtD
Pimozide—Cardiac disorder—Varenicline—nicotine dependence	0.00111	0.0131	CcSEcCtD
Pimozide—CHRM2—cardiovascular system—nicotine dependence	0.00109	0.0527	CbGeAlD
Pimozide—Mental disorder—Varenicline—nicotine dependence	0.00105	0.0123	CcSEcCtD
Pimozide—Muscle spasms—Varenicline—nicotine dependence	0.001	0.0118	CcSEcCtD
Pimozide—Vision blurred—Varenicline—nicotine dependence	0.000981	0.0115	CcSEcCtD
Pimozide—Tremor—Varenicline—nicotine dependence	0.000975	0.0115	CcSEcCtD
Pimozide—Anaemia—Varenicline—nicotine dependence	0.000962	0.0113	CcSEcCtD
Pimozide—Agitation—Varenicline—nicotine dependence	0.000956	0.0112	CcSEcCtD
Pimozide—Syncope—Varenicline—nicotine dependence	0.000933	0.011	CcSEcCtD
Pimozide—OPRM1—midbrain—nicotine dependence	0.000932	0.0452	CbGeAlD
Pimozide—DRD3—brain—nicotine dependence	0.000924	0.0448	CbGeAlD
Pimozide—Fluspirilene—DRD2—nicotine dependence	0.000922	0.199	CrCbGaD
Pimozide—Palpitations—Varenicline—nicotine dependence	0.00092	0.0108	CcSEcCtD
Pimozide—Loss of consciousness—Varenicline—nicotine dependence	0.000915	0.0108	CcSEcCtD
Pimozide—Convulsion—Varenicline—nicotine dependence	0.000902	0.0106	CcSEcCtD
Pimozide—Hypertension—Varenicline—nicotine dependence	0.000899	0.0106	CcSEcCtD
Pimozide—HTR6—brain—nicotine dependence	0.000889	0.0431	CbGeAlD
Pimozide—Myalgia—Varenicline—nicotine dependence	0.000886	0.0104	CcSEcCtD
Pimozide—Chest pain—Varenicline—nicotine dependence	0.000886	0.0104	CcSEcCtD
Pimozide—HTR1A—cardiovascular system—nicotine dependence	0.000881	0.0427	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00088	0.0103	CcSEcCtD
Pimozide—Dry mouth—Varenicline—nicotine dependence	0.000867	0.0102	CcSEcCtD
Pimozide—CALM2—cardiovascular system—nicotine dependence	0.000866	0.042	CbGeAlD
Pimozide—CALM1—cardiovascular system—nicotine dependence	0.000862	0.0418	CbGeAlD
Pimozide—CALM3—midbrain—nicotine dependence	0.000861	0.0418	CbGeAlD
Pimozide—Shock—Varenicline—nicotine dependence	0.000836	0.00983	CcSEcCtD
Pimozide—Nervous system disorder—Varenicline—nicotine dependence	0.000833	0.0098	CcSEcCtD
Pimozide—Tachycardia—Varenicline—nicotine dependence	0.000829	0.00975	CcSEcCtD
Pimozide—Domperidone—DRD2—nicotine dependence	0.000825	0.178	CrCbGaD
Pimozide—Skin disorder—Varenicline—nicotine dependence	0.000825	0.0097	CcSEcCtD
Pimozide—OPRK1—brain—nicotine dependence	0.000823	0.0399	CbGeAlD
Pimozide—Hyperhidrosis—Varenicline—nicotine dependence	0.000821	0.00966	CcSEcCtD
Pimozide—Anorexia—Varenicline—nicotine dependence	0.00081	0.00952	CcSEcCtD
Pimozide—Hypotension—Varenicline—nicotine dependence	0.000794	0.00934	CcSEcCtD
Pimozide—KCNH2—cardiovascular system—nicotine dependence	0.000785	0.0381	CbGeAlD
Pimozide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000774	0.0091	CcSEcCtD
Pimozide—Insomnia—Varenicline—nicotine dependence	0.000768	0.00904	CcSEcCtD
Pimozide—Somnolence—Varenicline—nicotine dependence	0.000755	0.00888	CcSEcCtD
Pimozide—Decreased appetite—Varenicline—nicotine dependence	0.000738	0.00868	CcSEcCtD
Pimozide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000733	0.00862	CcSEcCtD
Pimozide—Constipation—Varenicline—nicotine dependence	0.000726	0.00854	CcSEcCtD
Pimozide—HTR1A—midbrain—nicotine dependence	0.000688	0.0334	CbGeAlD
Pimozide—CALM2—midbrain—nicotine dependence	0.000676	0.0328	CbGeAlD
Pimozide—Urticaria—Varenicline—nicotine dependence	0.000675	0.00794	CcSEcCtD
Pimozide—CALM1—midbrain—nicotine dependence	0.000673	0.0327	CbGeAlD
Pimozide—DRD2—midbrain—nicotine dependence	0.000622	0.0302	CbGeAlD
Pimozide—KCNH2—midbrain—nicotine dependence	0.000613	0.0297	CbGeAlD
Pimozide—Asthenia—Varenicline—nicotine dependence	0.000609	0.00717	CcSEcCtD
Pimozide—CYP2E1—cardiovascular system—nicotine dependence	0.000604	0.0293	CbGeAlD
Pimozide—Pruritus—Varenicline—nicotine dependence	0.000601	0.00707	CcSEcCtD
Pimozide—OPRM1—brain—nicotine dependence	0.000586	0.0284	CbGeAlD
Pimozide—Diarrhoea—Varenicline—nicotine dependence	0.000581	0.00684	CcSEcCtD
Pimozide—Dizziness—Varenicline—nicotine dependence	0.000562	0.00661	CcSEcCtD
Pimozide—CALM3—brain—nicotine dependence	0.000541	0.0263	CbGeAlD
Pimozide—Vomiting—Varenicline—nicotine dependence	0.00054	0.00635	CcSEcCtD
Pimozide—Rash—Varenicline—nicotine dependence	0.000536	0.0063	CcSEcCtD
Pimozide—Dermatitis—Varenicline—nicotine dependence	0.000535	0.00629	CcSEcCtD
Pimozide—CHRM2—brain—nicotine dependence	0.000533	0.0259	CbGeAlD
Pimozide—Headache—Varenicline—nicotine dependence	0.000532	0.00626	CcSEcCtD
Pimozide—HTR2A—cardiovascular system—nicotine dependence	0.000525	0.0255	CbGeAlD
Pimozide—Nausea—Varenicline—nicotine dependence	0.000505	0.00593	CcSEcCtD
Pimozide—HTR1A—brain—nicotine dependence	0.000432	0.021	CbGeAlD
Pimozide—CALM2—brain—nicotine dependence	0.000425	0.0206	CbGeAlD
Pimozide—CALM1—brain—nicotine dependence	0.000423	0.0205	CbGeAlD
Pimozide—HTR2A—midbrain—nicotine dependence	0.00041	0.0199	CbGeAlD
Pimozide—DRD2—brain—nicotine dependence	0.000391	0.019	CbGeAlD
Pimozide—KCNH2—brain—nicotine dependence	0.000385	0.0187	CbGeAlD
Pimozide—ABCB1—cardiovascular system—nicotine dependence	0.000344	0.0167	CbGeAlD
Pimozide—HRH1—brain—nicotine dependence	0.000309	0.015	CbGeAlD
Pimozide—CYP2E1—brain—nicotine dependence	0.000297	0.0144	CbGeAlD
Pimozide—ABCB1—midbrain—nicotine dependence	0.000269	0.013	CbGeAlD
Pimozide—HTR2A—brain—nicotine dependence	0.000258	0.0125	CbGeAlD
Pimozide—CYP2D6—brain—nicotine dependence	0.000235	0.0114	CbGeAlD
Pimozide—ABCB1—brain—nicotine dependence	0.000169	0.00819	CbGeAlD
Pimozide—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.00013	0.00107	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.000128	0.00105	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000127	0.00104	CbGpPWpGaD
Pimozide—CALM3—Neuronal System—CHRNA5—nicotine dependence	0.000127	0.00104	CbGpPWpGaD
Pimozide—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000127	0.00104	CbGpPWpGaD
Pimozide—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000127	0.00104	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000126	0.00103	CbGpPWpGaD
Pimozide—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000125	0.00103	CbGpPWpGaD
Pimozide—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000125	0.00102	CbGpPWpGaD
Pimozide—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000124	0.00101	CbGpPWpGaD
Pimozide—DRD3—G alpha (i) signalling events—DRD2—nicotine dependence	0.000124	0.00101	CbGpPWpGaD
Pimozide—CALM2—Neuronal System—CHRNA5—nicotine dependence	0.000123	0.00101	CbGpPWpGaD
Pimozide—CALM1—Neuronal System—CHRNA5—nicotine dependence	0.000123	0.00101	CbGpPWpGaD
Pimozide—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.000122	0.001	CbGpPWpGaD
Pimozide—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000122	0.000996	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000121	0.000993	CbGpPWpGaD
Pimozide—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00012	0.00098	CbGpPWpGaD
Pimozide—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000119	0.000978	CbGpPWpGaD
Pimozide—CALM3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000119	0.000976	CbGpPWpGaD
Pimozide—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000119	0.000972	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000118	0.000969	CbGpPWpGaD
Pimozide—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000118	0.000964	CbGpPWpGaD
Pimozide—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000117	0.000963	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.000117	0.000955	CbGpPWpGaD
Pimozide—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000116	0.00095	CbGpPWpGaD
Pimozide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000116	0.00095	CbGpPWpGaD
Pimozide—CALM2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000115	0.000944	CbGpPWpGaD
Pimozide—CALM1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000115	0.000944	CbGpPWpGaD
Pimozide—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000115	0.000941	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00011	0.000902	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00011	0.000901	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—FGD1—nicotine dependence	0.000109	0.000894	CbGpPWpGaD
Pimozide—CALM3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000108	0.000886	CbGpPWpGaD
Pimozide—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000108	0.000884	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000106	0.000871	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000105	0.000857	CbGpPWpGaD
Pimozide—CALM2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000105	0.000857	CbGpPWpGaD
Pimozide—CALM1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000105	0.000857	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000104	0.000856	CbGpPWpGaD
Pimozide—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000104	0.000854	CbGpPWpGaD
Pimozide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000104	0.000852	CbGpPWpGaD
Pimozide—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.000104	0.00085	CbGpPWpGaD
Pimozide—CALM3—Neuronal System—CHRNA3—nicotine dependence	0.000104	0.000849	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000103	0.000842	CbGpPWpGaD
Pimozide—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000102	0.00084	CbGpPWpGaD
Pimozide—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000102	0.000838	CbGpPWpGaD
Pimozide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000101	0.000825	CbGpPWpGaD
Pimozide—CALM2—Neuronal System—CHRNA3—nicotine dependence	0.0001	0.000821	CbGpPWpGaD
Pimozide—CALM1—Neuronal System—CHRNA3—nicotine dependence	0.0001	0.000821	CbGpPWpGaD
Pimozide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0001	0.00082	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.0001	0.000819	CbGpPWpGaD
Pimozide—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.93e-05	0.000814	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—FGD1—nicotine dependence	9.9e-05	0.000812	CbGpPWpGaD
Pimozide—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.84e-05	0.000807	CbGpPWpGaD
Pimozide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	9.8e-05	0.000803	CbGpPWpGaD
Pimozide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	9.67e-05	0.000792	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	9.65e-05	0.000791	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	9.5e-05	0.000779	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	9.5e-05	0.000779	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	9.48e-05	0.000777	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	9.33e-05	0.000765	CbGpPWpGaD
Pimozide—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	9.15e-05	0.00075	CbGpPWpGaD
Pimozide—CALM3—Neuronal System—CHRNB2—nicotine dependence	9.12e-05	0.000747	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	9.03e-05	0.00074	CbGpPWpGaD
Pimozide—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	8.95e-05	0.000734	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	8.9e-05	0.00073	CbGpPWpGaD
Pimozide—HTR6—GPCR ligand binding—DRD2—nicotine dependence	8.82e-05	0.000723	CbGpPWpGaD
Pimozide—CALM2—Neuronal System—CHRNB2—nicotine dependence	8.82e-05	0.000723	CbGpPWpGaD
Pimozide—CALM1—Neuronal System—CHRNB2—nicotine dependence	8.82e-05	0.000723	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	8.77e-05	0.000719	CbGpPWpGaD
Pimozide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	8.65e-05	0.000709	CbGpPWpGaD
Pimozide—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	8.63e-05	0.000707	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	8.63e-05	0.000707	CbGpPWpGaD
Pimozide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.57e-05	0.000703	CbGpPWpGaD
Pimozide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	8.49e-05	0.000696	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	8.34e-05	0.000684	CbGpPWpGaD
Pimozide—CALM3—Neuronal System—CHRNA4—nicotine dependence	8.28e-05	0.000679	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	8.21e-05	0.000673	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	8.19e-05	0.000671	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	8.06e-05	0.000661	CbGpPWpGaD
Pimozide—CALM1—Neuronal System—CHRNA4—nicotine dependence	8.01e-05	0.000657	CbGpPWpGaD
Pimozide—CALM2—Neuronal System—CHRNA4—nicotine dependence	8.01e-05	0.000657	CbGpPWpGaD
Pimozide—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	7.93e-05	0.00065	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—TAS2R16—nicotine dependence	7.88e-05	0.000646	CbGpPWpGaD
Pimozide—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	7.8e-05	0.00064	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	7.79e-05	0.000638	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	7.66e-05	0.000628	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—TAS2R16—nicotine dependence	7.63e-05	0.000625	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—TAS2R16—nicotine dependence	7.63e-05	0.000625	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—FGD1—nicotine dependence	7.58e-05	0.000621	CbGpPWpGaD
Pimozide—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	7.56e-05	0.00062	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	7.52e-05	0.000617	CbGpPWpGaD
Pimozide—DRD3—GPCR ligand binding—DRD2—nicotine dependence	7.49e-05	0.000614	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	7.45e-05	0.000611	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	7.45e-05	0.000611	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—FGD1—nicotine dependence	7.44e-05	0.00061	CbGpPWpGaD
Pimozide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	7.41e-05	0.000607	CbGpPWpGaD
Pimozide—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	7.39e-05	0.000606	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	7.32e-05	0.0006	CbGpPWpGaD
Pimozide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	7.27e-05	0.000596	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	7e-05	0.000574	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—FGD1—nicotine dependence	6.99e-05	0.000573	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	6.9e-05	0.000565	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—FGD1—nicotine dependence	6.89e-05	0.000564	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	6.53e-05	0.000535	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	6.5e-05	0.000532	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	6.35e-05	0.000521	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	6.26e-05	0.000513	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—FGD1—nicotine dependence	6.19e-05	0.000507	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	6.17e-05	0.000506	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	6.08e-05	0.000499	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—WASF2—nicotine dependence	6.04e-05	0.000495	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—FGD1—nicotine dependence	5.99e-05	0.000491	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—FGD1—nicotine dependence	5.99e-05	0.000491	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—FGD1—nicotine dependence	5.9e-05	0.000484	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	5.86e-05	0.00048	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—FGD1—nicotine dependence	5.85e-05	0.000479	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—WASF2—nicotine dependence	5.84e-05	0.000479	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—WASF2—nicotine dependence	5.84e-05	0.000479	CbGpPWpGaD
Pimozide—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	5.81e-05	0.000476	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—WASF1—nicotine dependence	5.79e-05	0.000475	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	5.7e-05	0.000467	CbGpPWpGaD
Pimozide—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	5.64e-05	0.000462	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—DRD2—nicotine dependence	5.63e-05	0.000461	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	5.61e-05	0.00046	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—WASF1—nicotine dependence	5.6e-05	0.000459	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—WASF1—nicotine dependence	5.6e-05	0.000459	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	5.6e-05	0.000459	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	5.54e-05	0.000454	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	5.51e-05	0.000452	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	5.32e-05	0.000436	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	5.22e-05	0.000428	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	5.17e-05	0.000423	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.1e-05	0.000418	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—FGD1—nicotine dependence	5.1e-05	0.000418	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	5.06e-05	0.000415	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—CYP2A7—nicotine dependence	4.99e-05	0.000409	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	4.99e-05	0.000409	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TAS2R16—nicotine dependence	4.66e-05	0.000382	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	4.63e-05	0.00038	CbGpPWpGaD
Pimozide—CALM3—Disease—AKR1B10—nicotine dependence	4.61e-05	0.000378	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	4.59e-05	0.000377	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—DRD2—nicotine dependence	4.53e-05	0.000371	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TAS2R16—nicotine dependence	4.51e-05	0.000369	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TAS2R16—nicotine dependence	4.51e-05	0.000369	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	4.5e-05	0.000369	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	4.48e-05	0.000367	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—FGD1—nicotine dependence	4.47e-05	0.000367	CbGpPWpGaD
Pimozide—CALM2—Disease—AKR1B10—nicotine dependence	4.46e-05	0.000366	CbGpPWpGaD
Pimozide—CALM1—Disease—AKR1B10—nicotine dependence	4.46e-05	0.000366	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	4.41e-05	0.000361	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—FGD1—nicotine dependence	4.4e-05	0.000361	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	4.4e-05	0.000361	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—FGD1—nicotine dependence	4.39e-05	0.00036	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—WASF2—nicotine dependence	4.35e-05	0.000356	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	4.33e-05	0.000355	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—FGD1—nicotine dependence	4.32e-05	0.000354	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—WASF2—nicotine dependence	4.29e-05	0.000351	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	4.28e-05	0.00035	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	4.23e-05	0.000347	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—WASF1—nicotine dependence	4.17e-05	0.000342	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—WASF1—nicotine dependence	4.11e-05	0.000337	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	4.07e-05	0.000334	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	4e-05	0.000328	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	4e-05	0.000328	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	3.95e-05	0.000324	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	3.93e-05	0.000322	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	3.89e-05	0.000319	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	3.88e-05	0.000318	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	3.88e-05	0.000318	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—DRD2—nicotine dependence	3.84e-05	0.000315	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	3.82e-05	0.000313	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	3.75e-05	0.000308	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—OPRM1—nicotine dependence	3.7e-05	0.000303	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	3.69e-05	0.000302	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—WASF2—nicotine dependence	3.67e-05	0.000301	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—FGD1—nicotine dependence	3.66e-05	0.0003	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—WASF2—nicotine dependence	3.64e-05	0.000298	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—CYP2A7—nicotine dependence	3.61e-05	0.000296	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—CYP2A7—nicotine dependence	3.61e-05	0.000296	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CYP2A7—nicotine dependence	3.59e-05	0.000294	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—FGD1—nicotine dependence	3.54e-05	0.00029	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—FGD1—nicotine dependence	3.54e-05	0.00029	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—WASF1—nicotine dependence	3.52e-05	0.000289	CbGpPWpGaD
Pimozide—CALM3—Immune System—WASF2—nicotine dependence	3.52e-05	0.000288	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—WASF1—nicotine dependence	3.49e-05	0.000286	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CYP2A7—nicotine dependence	3.47e-05	0.000285	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CYP2A7—nicotine dependence	3.47e-05	0.000285	CbGpPWpGaD
Pimozide—CALM1—Immune System—WASF2—nicotine dependence	3.4e-05	0.000279	CbGpPWpGaD
Pimozide—CALM2—Immune System—WASF2—nicotine dependence	3.4e-05	0.000279	CbGpPWpGaD
Pimozide—CALM3—Immune System—WASF1—nicotine dependence	3.37e-05	0.000277	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	3.35e-05	0.000275	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—OPRM1—nicotine dependence	3.32e-05	0.000272	CbGpPWpGaD
Pimozide—CALM2—Immune System—WASF1—nicotine dependence	3.26e-05	0.000267	CbGpPWpGaD
Pimozide—CALM1—Immune System—WASF1—nicotine dependence	3.26e-05	0.000267	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKR1B10—nicotine dependence	3.23e-05	0.000265	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—OPRM1—nicotine dependence	3.22e-05	0.000264	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—OPRM1—nicotine dependence	3.22e-05	0.000264	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	3.19e-05	0.000261	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	3.18e-05	0.000261	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—WASF2—nicotine dependence	3.17e-05	0.00026	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—OPRM1—nicotine dependence	3.14e-05	0.000258	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	3.13e-05	0.000257	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKR1B10—nicotine dependence	3.12e-05	0.000256	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKR1B10—nicotine dependence	3.12e-05	0.000256	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—WASF1—nicotine dependence	3.04e-05	0.000249	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	2.89e-05	0.000237	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—DRD2—nicotine dependence	2.89e-05	0.000237	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	2.84e-05	0.000233	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CYP2A7—nicotine dependence	2.79e-05	0.000228	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—WASF2—nicotine dependence	2.78e-05	0.000228	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—WASF2—nicotine dependence	2.74e-05	0.000225	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	2.74e-05	0.000224	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—WASF2—nicotine dependence	2.73e-05	0.000224	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CYP2A7—nicotine dependence	2.72e-05	0.000223	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—DRD2—nicotine dependence	2.71e-05	0.000222	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—WASF2—nicotine dependence	2.69e-05	0.000221	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—DRD2—nicotine dependence	2.67e-05	0.000219	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—WASF1—nicotine dependence	2.67e-05	0.000219	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—WASF1—nicotine dependence	2.63e-05	0.000215	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—WASF1—nicotine dependence	2.62e-05	0.000215	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—WASF1—nicotine dependence	2.58e-05	0.000211	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CYP2A7—nicotine dependence	2.56e-05	0.00021	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—OPRM1—nicotine dependence	2.4e-05	0.000197	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD2—nicotine dependence	2.4e-05	0.000197	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	2.37e-05	0.000194	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—OPRM1—nicotine dependence	2.36e-05	0.000193	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD2—nicotine dependence	2.32e-05	0.000191	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD2—nicotine dependence	2.32e-05	0.000191	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	2.32e-05	0.00019	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD2—nicotine dependence	2.29e-05	0.000188	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—WASF2—nicotine dependence	2.27e-05	0.000186	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—DRD2—nicotine dependence	2.27e-05	0.000186	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—WASF2—nicotine dependence	2.2e-05	0.00018	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—WASF2—nicotine dependence	2.2e-05	0.00018	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—WASF1—nicotine dependence	2.18e-05	0.000179	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CYP2A7—nicotine dependence	2.17e-05	0.000178	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—WASF1—nicotine dependence	2.11e-05	0.000173	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—WASF1—nicotine dependence	2.11e-05	0.000173	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD2—nicotine dependence	1.98e-05	0.000162	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—OPRM1—nicotine dependence	1.96e-05	0.000161	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—OPRM1—nicotine dependence	1.9e-05	0.000156	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—OPRM1—nicotine dependence	1.9e-05	0.000156	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD2—nicotine dependence	1.71e-05	0.00014	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD2—nicotine dependence	1.71e-05	0.00014	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD2—nicotine dependence	1.68e-05	0.000138	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	1.68e-05	0.000137	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD2—nicotine dependence	1.42e-05	0.000116	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD2—nicotine dependence	1.37e-05	0.000113	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD2—nicotine dependence	1.37e-05	0.000113	CbGpPWpGaD
